Food Allergy Registry at a Single Site

November 12, 2025 updated by: R. Sharon Chinthrajah, Stanford University
This is a registry of participants who are interested in being screened for clinical trials at a single site.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This registry will be maintained on a secure database and will include demographics information such as name, gender, age, date of birth, ethnicity, race, and contact information, disease, medical information, other information (via questionnaires), and date of consent. It will be overseen by our data manager at our site and will not be shared with others outside of our site-specific trained individuals.

Study Type

Observational

Enrollment (Estimated)

6000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 100 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Any interested party from 0-100 yrs of age to enter their information in registry

Description

Inclusion Criteria:

  • Any interested party from 0-100 yrs of age to enter their information in registry

Exclusion Criteria:

  • Any individual who does not consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Registry to provide a list of interested individuals in clinical trials at a single site
Time Frame: 4 years
The clinical trials could be either allergy or asthma studies
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sharon Chinthrajah, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2018

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Study Registration Dates

First Submitted

May 16, 2018

First Submitted That Met QC Criteria

May 16, 2018

First Posted (Actual)

May 29, 2018

Study Record Updates

Last Update Posted (Estimated)

November 14, 2025

Last Update Submitted That Met QC Criteria

November 12, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 36273
  • 1UM1AI130839-01 (U.S. NIH Grant/Contract)
  • 1U01AI182039-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Allergy and Asthma

Clinical Trials on There is no intervention

Subscribe